65岁以上女性直接置入假体乳房重建:并发症率与总体结局的回顾性分析
该回顾性图表综述比较了65岁以上女性直接置入假体与组织扩张器/假体乳房重建的并发症与结局,直接置入组引流量天数、住院时间、再入院、额外住院天数和术后随访次数均显著减少,并发症与失败率相似。
要点
- 直接置入假体组引流天数、住院时间、再入院、额外住院天数和术后随访次数均显著少于组织扩张器/假体组。
- 两组血清肿、血肿、感染、坏死或重建失败率无差异。
- 作者认为直接置入假体是适用于乳房形态和下垂程度合适的老年女性的有力工具。
核心结论
- 老年女性直接置入假体乳房重建的并发症率和失败率与组织扩张器/假体重建相似,但引流量天数、再入院、住院时间和术后随访次数更少。
研究设计与样本
- 经机构审查委员会批准的回顾性图表综述,纳入2012年至2015年由作者科室任何工作人员行直接置入假体重建的患者,并分析同期行组织扩张器/假体重建的对照队列。
- 直接置入假体组随访至少30天的为19例患者24侧乳房,随访至少1年的为14例患者17侧乳房;组织扩张器/假体对照组为88例患者109侧乳房。
主要发现
- 组织扩张器/假体组显著更年轻(p=0.001),体重指数更低(p=0.004)。
- 两组血清肿、血肿、感染、坏死或重建失败率无差异。
- 直接置入假体组引流量天数显著减少(p<0.001)。
- 直接置入假体组住院时间(p=0.05和p=0.039)、再入院(p=0.03和0.03)、额外住院天数(p=0.05和0.045)和术后随访次数(p<0.001)均显著减少。
临床怎么用
- 作者认为,对于乳房形态和下垂程度合适的老年女性,直接置入假体乳房重建是有力的工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Half of all cancers occur in women older than 65 years, yet only 4 to 14 percent of these women undergo reconstruction. Most studies on reconstruction in the elderly have focused on tissue expander/implant or autologous reconstruction. A direct-to-implant approach theoretically reduces the number of operations and postoperative visits, but has yet to be investigated in the elderly. METHODS: Institutional review board approval was granted for a retrospective chart review for patients who underwent direct-to-implant reconstruction from 2012 to 2015 with any staff in the authors' department. A control cohort of patients who underwent tissue expander/implant-based reconstruction from the same period was analyzed. RESULTS: Direct-to-implant reconstruction was performed in 24 breasts in 19 patients with at least 30-day follow-up and in 17 breasts in 14 patients with at least 1-year follow-up. A control group analysis of tissue expander/implant patients was performed for 109 breasts in 88 patients. The tissue expander/implant group was significantly younger (p = 0.001), with a lower body mass index (p = 0.004). There was no difference in the rate of seroma, hematoma, infection, necrosis, or failed reconstruction. Direct-to-implant patients had significantly reduced numbers of drain days (p < 0.001), length of stay (p = 0.05 and p = 0.039), readmissions (p = 0.03 and 0.03), extra hospital days (p = 0.05 and p = 0.045), and postoperative visits (p < 0.001). CONCLUSIONS: Direct-to-implant breast reconstruction in the elderly yields similar complication and failure rates compared to tissue expander/implant reconstruction. However, direct-to-implant reconstruction patients had a reduced number of drain days and fewer readmissions, hospital stays, and postoperative visits. Direct-to-implant reconstruction is a powerful tool to use in elderly women with appropriate breast shape and ptosis. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Knackstedt R, Gatherwright J, Moreira A, et al. Direct-to-Implant Breast Reconstruction in Women Older than 65 Years: A Retrospective Analysis of Complication Rate and Overall Outcomes. Plast Reconstr Surg. 2018. PMID: 29369976. doi:10.1097/PRS.0000000000004015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。